| Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net Loss | 123,764 | 1 | -91,300 | -10,884,058 | -20,324,648 | -38,726,259 | -19,935,112 | -6,168,177 |
|---|
| Stock-based compensation | - | - | - | 1 | - | - | 2 | - |
|---|
| Shares issued for services | - | - | - | - | 2 | 331,591 | 89,189 | - |
|---|
| Amortization of stock options and restricted stock units | - | - | - | - | - | - | - | 308,169 |
|---|
| Depreciation and amortization | - | - | - | - | - | - | - | 58,277 |
|---|
| Loss on asset impairment | - | - | - | - | - | -3,342,084 | - | -1,526,542 |
|---|
| Change in fair value of derivative liabilities | - | - | - | 2 | 5 | -15,144,986 | -75,323 | -58 |
|---|
| Change in fair value of preferred stock liability | - | - | - | - | - | - | - | 2 |
|---|
| Gain on settlement of liabilities | - | - | - | - | - | - | - | 222,802 |
|---|
| Deferred tax benefit | - | - | - | - | - | - | -2,349,683 | -292,417 |
|---|
| Prepaid expenses and other current assets | - | - | - | 210,195 | 1 | -1,018,303 | -337,282 | -1,874,958 |
|---|
| Accounts payable | - | - | - | - | - | - | - | -243,524 |
|---|
| Accounts payable - related parties | - | - | - | - | - | - | - | 417,273 |
|---|
| Accrued expenses | - | - | - | -9,405 | -1,646,657 | 319,936 | -440,621 | -316,113 |
|---|
| Accrued expenses - related parties | - | - | - | - | - | 169,788 | - | - |
|---|
| Total adjustments | - | - | - | - | - | - | 9 | 5 |
|---|
| Net Cash Used In Operating Activities | -497,357 | -789,230 | -1,452,235 | -3,871,961 | -19,371,428 | -12,127,585 | -10,922,223 | -1,480,567 |
|---|
| Proceeds from exercise of pre-funded warrants from the Amendment to August 2023 Offering | - | - | - | - | - | - | - | 489 |
|---|
| Proceeds from sale of December 2024 Offering stock and warrants | - | - | - | - | - | - | - | 3 |
|---|
| Proceeds from the exercise of warrants | - | - | - | - | - | - | - | 3 |
|---|
| Proceeds from loans payable | - | - | - | - | - | - | 969,322 | - |
|---|
| Repayment of loans payable | 191,521 | - | - | - | - | - | - | 1 |
|---|
| Net cash provided by financing activities | 117 | 156,844 | -106,508,638 | - | 25 | 11 | 6 | 4 |
|---|
| Effect of Exchange Rate Changes on Cash | - | - | - | - | - | - | 20,025 | 52,194 |
|---|
| Net Decrease In Cash | - | - | - | - | 6 | -1,254,398 | -4,994,311 | 3 |
|---|
| Cash paid during the period for income taxes | 225,000 | - | - | - | - | - | - | - |
|---|
| Cash paid during the period for interest expense | - | - | - | - | 35,351 | 15,060 | 21,722 | 12,078 |
|---|
| Common stock issued for settlement of liabilities | - | - | - | - | - | - | - | 684,671 |
|---|
| Prepaid expense financed with notes payable | - | - | - | - | - | - | - | 777,702 |
|---|
| Warrants and Series B Convertible Preferred Stock issued for asset acquisition | - | - | - | - | - | - | - | 8 |
|---|
| Deemed dividend from warrant inducement | - | - | - | - | - | - | - | 8 |
|---|